Resynchronization therapy and sudden death management in congenitally corrected transposition: Submitted by Damien Cullington, MBChB (hons), MD, MRCP, FESC

Seshadri Balaji; Ravi Mandapati; Gary D. Webb

doi:10.1016/B978-0-323-48568-5.00008-1

Resynchronization therapy and sudden death management in congenitally corrected transposition: Submitted by Damien Cullington, MBChB (hons), MD, MRCP, FESC

Seshadri Balaji, Ravi Mandapati, Gary D. Webb

Pediatrics

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

1. Whenever possible, use only MRI-compatible devices in patients with CHD. 2. CRT should be considered as an important therapeutic option in patients with systemic ventricular failure. 3. All intracardiac shunts should be eliminated prior to placement of an endocardial device. 4. In ACHD patients who do not respond to pharmacologic therapy for AF, catheter ablation of either all pulmonary veins or culprit veins should be considered. 5. β blocker therapy should be considered in all ACHD patients with systemic ventricular dysfunction and NSVT.

Original language	English (US)
Title of host publication	Arrhythmias in Adult Congenital Heart Disease
Subtitle of host publication	A Case-Based Approach
Publisher	Elsevier
Pages	59-68
Number of pages	10
ISBN (Electronic)	9780323485685
ISBN (Print)	9780323496094
DOIs	https://doi.org/10.1016/B978-0-323-48568-5.00008-1
State	Published - Jan 1 2018

Keywords

Cardiac resynchronization therapy
Complete heart block
Congenitally corrected transposition of the great arteries
Risk stratification
Sudden cardiac death
Systemic right ventricle

ASJC Scopus subject areas

General Medicine

Access to Document

10.1016/B978-0-323-48568-5.00008-1

Cite this

Resynchronization therapy and sudden death management in congenitally corrected transposition: Submitted by Damien Cullington, MBChB (hons), MD, MRCP, FESC. / Balaji, Seshadri; Mandapati, Ravi; Webb, Gary D.
Arrhythmias in Adult Congenital Heart Disease: A Case-Based Approach. Elsevier, 2018. p. 59-68.

Research output: Chapter in Book/Report/Conference proceeding › Chapter

@inbook{b88e9639984f4ec0b37c9cde05927dc1,

title = "Resynchronization therapy and sudden death management in congenitally corrected transposition: Submitted by Damien Cullington, MBChB (hons), MD, MRCP, FESC",

abstract = "1. Whenever possible, use only MRI-compatible devices in patients with CHD. 2. CRT should be considered as an important therapeutic option in patients with systemic ventricular failure. 3. All intracardiac shunts should be eliminated prior to placement of an endocardial device. 4. In ACHD patients who do not respond to pharmacologic therapy for AF, catheter ablation of either all pulmonary veins or culprit veins should be considered. 5. β blocker therapy should be considered in all ACHD patients with systemic ventricular dysfunction and NSVT.",

keywords = "Cardiac resynchronization therapy, Complete heart block, Congenitally corrected transposition of the great arteries, Risk stratification, Sudden cardiac death, Systemic right ventricle",

author = "Seshadri Balaji and Ravi Mandapati and Webb, {Gary D.}",

year = "2018",

month = jan,

day = "1",

doi = "10.1016/B978-0-323-48568-5.00008-1",

language = "English (US)",

isbn = "9780323496094",

pages = "59--68",

booktitle = "Arrhythmias in Adult Congenital Heart Disease",

publisher = "Elsevier",

}

TY - CHAP

T1 - Resynchronization therapy and sudden death management in congenitally corrected transposition

T2 - Submitted by Damien Cullington, MBChB (hons), MD, MRCP, FESC

AU - Balaji, Seshadri

AU - Mandapati, Ravi

AU - Webb, Gary D.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - 1. Whenever possible, use only MRI-compatible devices in patients with CHD. 2. CRT should be considered as an important therapeutic option in patients with systemic ventricular failure. 3. All intracardiac shunts should be eliminated prior to placement of an endocardial device. 4. In ACHD patients who do not respond to pharmacologic therapy for AF, catheter ablation of either all pulmonary veins or culprit veins should be considered. 5. β blocker therapy should be considered in all ACHD patients with systemic ventricular dysfunction and NSVT.

AB - 1. Whenever possible, use only MRI-compatible devices in patients with CHD. 2. CRT should be considered as an important therapeutic option in patients with systemic ventricular failure. 3. All intracardiac shunts should be eliminated prior to placement of an endocardial device. 4. In ACHD patients who do not respond to pharmacologic therapy for AF, catheter ablation of either all pulmonary veins or culprit veins should be considered. 5. β blocker therapy should be considered in all ACHD patients with systemic ventricular dysfunction and NSVT.

KW - Cardiac resynchronization therapy

KW - Complete heart block

KW - Congenitally corrected transposition of the great arteries

KW - Risk stratification

KW - Sudden cardiac death

KW - Systemic right ventricle

UR - http://www.scopus.com/inward/record.url?scp=85092560418&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85092560418&partnerID=8YFLogxK

U2 - 10.1016/B978-0-323-48568-5.00008-1

DO - 10.1016/B978-0-323-48568-5.00008-1

M3 - Chapter

AN - SCOPUS:85092560418

SN - 9780323496094

SP - 59

EP - 68

BT - Arrhythmias in Adult Congenital Heart Disease

PB - Elsevier

ER -

Resynchronization therapy and sudden death management in congenitally corrected transposition: Submitted by Damien Cullington, MBChB (hons), MD, MRCP, FESC

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this